By Scientia Professor Vlado Perkovic

Journal articles

Levin A; Perkovic V, 2013, 'Epidemiology: Global Burden of Disease Study 2010: Implications for nephrology', Nature Reviews Nephrology, 9, pp. 195 - 197, http://dx.doi.org/10.1038/nrneph.2013.38

Mooney JF; Ranasinghe I; Chow CK; Perkovic V; Barzi F; Zoungas S; Holzmann MJ; Welten GM; Biancari F; Wu VC; Tan TC; Cass A; Hillis GS, 2013, 'Preoperative estimates of glomerular filtration rate as predictors of outcome after surgery: A systematic review and meta-analysis', Anesthesiology, 118, pp. 809 - 824, http://dx.doi.org/10.1097/ALN.0b013e318287b72c

Jardine MJ; Liyanage T; Buxton E; Perkovic V, 2013, 'MTOR inhibition in autosomal-dominant polycystic kidney disease (ADPKD): The question remains open', Nephrology Dialysis Transplantation, 28, pp. 242 - 244, http://dx.doi.org/10.1093/ndt/gfs519

Jun M; Jardine MJ; Gray N; Masterson R; Kerr PG; Agar JWM; Hawley CM; Van Eps C; Cass A; Gallagher M; Perkovic V, 2013, 'Outcomes of extended-hours hemodialysis performed predominantly at home', American Journal of Kidney Diseases, 61, pp. 247 - 253, http://dx.doi.org/10.1053/j.ajkd.2012.08.032

Wang AY; Ivany JN; Perkovic V; Gallagher MP; Jardine MJ, 2013, 'Anticoagulant therapies for the prevention of intravascular catheters malfunction in patients undergoing haemodialysis: Systematic review and meta-analysis of randomized, controlled trials', Nephrology Dialysis Transplantation, 28, pp. 2875 - 2888, http://dx.doi.org/10.1093/ndt/gft406

Palmer SC; Di Micco L; Razavian M; Craig JC; Perkovic V; Pellegrini F; Jardine MJ; Webster AC; Zoungas S; Strippoli GFM, 2013, 'Antiplatelet agents for chronic kidney disease', Cochrane Database of Systematic Reviews, 2013, http://dx.doi.org/10.1002/14651858.CD008834.pub3

Palmer SC; Di Micco L; Razavian M; Craig JC; Ravani P; Perkovic V; Tognoni G; Graziano G; Jardine M; Pellegrini F; Nicolucci A; Webster A; Strippoli GFM, 2013, 'Antiplatelet therapy to prevent hemodialysis vascular access failure: Systematic review and meta-analysis', American Journal of Kidney Diseases, 61, pp. 112 - 122, http://dx.doi.org/10.1053/j.ajkd.2012.08.031

Wong MG; Perkovic V; Woodward M; Chalmers J; Li Q; Hillis GS; Yaghobian Azari D; Jun M; Poulter N; Hamet P; Williams B; Neal B; Mancia G; Cooper M; Pollock CA, 2013, 'Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitus', Kidney International, 83, pp. 278 - 284, http://dx.doi.org/10.1038/ki.2012.383

Neuen BL; Taylor GE; Demaio AR; Perkovic V, 2013, 'Global kidney disease', The Lancet, 382, pp. 1243, http://dx.doi.org/10.1016/S0140-6736(13)62086-3

Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Nigwekar SU; Hegbrant J; Strippoli GFM, 2013, 'HMG CoA reductase inhibitors (statins) for dialysis patients', Cochrane Database of Systematic Reviews, 2013, http://dx.doi.org/10.1002/14651858.CD004289.pub5

Perkovic V; Heerspink HL; Chalmers J; Woodward M; Jun M; Li Q; Macmahon S; Cooper ME; Hamet P; Marre M; Mogensen CE; Poulter N; Mancia G; Cass A; Patel A; Zoungas S, 2013, 'Intensive glucose control improves kidney outcomes in patients with type 2 diabetes', Kidney International, 83, pp. 517 - 523, http://dx.doi.org/10.1038/ki.2012.401

Neal B; Perkovic V; De Zeeuw D; Mahaffey KW; Fulcher G; Stein P; Desai M; Shaw W; Jiang J; Vercruysse F; Meininger G; Matthews D, 2013, 'Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS) - A randomized placebo-controlled trial', American Heart Journal, 166, http://dx.doi.org/10.1016/j.ahj.2013.05.007

Perkovic V; Woodward M; Zoungas S; Chalmers J, 2013, 'The authors reply', Kidney International, 84, pp. 622, http://dx.doi.org/10.1038/ki.2013.241

Hillis G; Welsh P; Chalmers J; Chow C; Li Q; Perkovic V; Neal B; Zoungas S; Jun M; Poulter N; Mancia G; Williams B; Sattar N; Woodward M, 2013, 'The Relative and Combined Ability of High Sensitivity Cardiac Troponin T and N-Terminal pro-BNP to Predict Cardiovascular Events and Death in Patients with Type 2 Diabetes Mellitus', Heart, Lung and Circulation, 22, pp. S68 - S68, http://dx.doi.org/10.1016/j.hlc.2013.05.162

Perkovic V; Neal B, 2012, 'Trials in kidney disease - Time to EVOLVE', New England Journal of Medicine, 367, pp. 2541 - 2542, http://dx.doi.org/10.1056/NEJMe1212368

Lv J; Perkovic V; Foote CV; Craig ME; Craig JC; Strippoli GFM, 2012, 'Antihypertensive agents for preventing diabetic kidney disease', Cochrane Database of Systematic Reviews, 2012, http://dx.doi.org/10.1002/14651858.CD004136.pub3

Jun M; Zhu B; Tonelli M; Jardine MJ; Patel A; Neal B; Liyanage T; Keech A; Cass A; Perkovic V, 2012, 'Effects of fibrates in kidney disease: A systematic review and meta-analysis', Journal of the American College of Cardiology, 60, pp. 2061 - 2071, http://dx.doi.org/10.1016/j.jacc.2012.07.049

Kotwal S; Jun M; Sullivan D; Perkovic V; Neal B, 2012, 'Omega 3 fatty acids and cardiovascular outcomes: Systematic review and meta-analysis', Circulation: Cardiovascular Quality and Outcomes, 5, pp. 808 - 818, http://dx.doi.org/10.1161/CIRCOUTCOMES.112.966168

Jardine MJ; Hata J; Woodward M; Perkovic V; Ninomiya T; Arima H; Zoungas S; Cass A; Patel A; Marre M; Mancia G; Mogensen CE; Poulter N; Chalmers J, 2012, 'Prediction of kidney-related outcomes in patients with type 2 diabetes', American Journal of Kidney Diseases, 60, pp. 770 - 778, http://dx.doi.org/10.1053/j.ajkd.2012.04.025

Matthews DR; Fulcher G; Perkovic V; de Zeeuw D; Mahaffey KW; Rosenstock J; Davies M; Capuano G; Desai M; Shaw W; Vercruysse F; Meininger G; Neal B, 2012, 'Efficacy and safety of canagliflozin (CANA), an inhibitor of sodium glucose co-transporter 2 (SGLT2), added-on to insulin therapy plus /- oral agents in type 2 diabetes', DIABETOLOGIA, 55, pp. S314 - S315, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208826502080&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Foote C; Ninomiya T; Gallagher M; Perkovic V; Cass A; McDonald SP; Jardine M, 2012, 'Survival of elderly dialysis patients is predicted by both patient and practice characteristics', Nephrology Dialysis Transplantation, 27, pp. 3581 - 3587, http://dx.doi.org/10.1093/ndt/gfs096

Lv J; Neal B; Ehteshami P; Ninomiya T; Woodward M; Rodgers A; Wang H; MacMahon S; Turnbull F; Hillis G; Chalmers J; Perkovic V; Jun M, 2012, 'Effects of Intensive Blood Pressure Lowering on Cardiovascular and Renal Outcomes: A Systematic Review and Meta-Analysis', PLoS Medicine, 9, pp. e1001293, http://dx.doi.org/10.1371/journal.pmed.1001293

Wong G; Zoungas S; Lo S; Chalmers J; Cass A; Neal B; Woodward M; Perkovic V; Glasziou P; Williams B; Howard K; Chapman JR; Craig JC, 2012, 'The risk of cancer in people with diabetes and chronic kidney disease', Nephrology Dialysis Transplantation, 27, pp. 3337 - 3344, http://dx.doi.org/10.1093/ndt/gfs022

Perkovic V; Patil V; Wei L; Lv J; Petersen M; Patel A, 2012, 'Global randomized trials: The promise of India and China', Journal of Bone and Joint Surgery, 94, pp. 92 - 96, http://dx.doi.org/10.2106/JBJS.L.00274

Jardine MJ; Kang A; Zoungas S; Navaneethan SD; Ninomiya T; Nigwekar SU; Gallagher MP; Cass A; Strippoli G; Perkovic V, 2012, 'The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: Systematic review and meta-analysis', BMJ (Online), 344, pp. e3533, http://dx.doi.org/10.1136/bmj.e3533

McMahon LP; Cai MX; Baweja S; Holt SG; Kent AB; Perkovic V; Leikis MJ; Becker GJ, 2012, 'Mortality in dialysis patients may not be associated with ESA dose: A 2-year prospective observational study', BMC Nephrology, 13, http://dx.doi.org/10.1186/1471-2369-13-40

Razavian M; Heeley EL; Perkovic V; Zoungas S; Weekes A; Patel AA; Anderson CS; Chalmers JP; Cass A, 2012, 'Cardiovascular risk management in chronic kidney disease in general practice (the AusHEART study)', Nephrology Dialysis Transplantation, 27, pp. 1396 - 1402, http://dx.doi.org/10.1093/ndt/gfr599

Foote C; Perkovic V; Neal B, 2012, 'Effects of SGLT2 inhibitors on cardiovascular outcomes', Diabetes and Vascular Disease Research, 9, pp. 117 - 123, http://dx.doi.org/10.1177/1479164112441190

Palmer SC; Micco LD; Razavian M; Craig JC; Perkovic V; Pellegrini F; Copetti M; Graziano G; Tognoni G; Jardine M; Webster A; Nicolucci A; Zoungas S; Strippoli GFM, 2012, 'Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease:A systematic review and meta-analysis', Annals of Internal Medicine, 156, pp. 445 - 459, http://dx.doi.org/10.7326/0003-4819-156-6-201203200-00007

Lv J; Xu D; Perkovic V; Ma X; Johnson DW; Woodward M; Levin A; Zhang H; Wang H, 2012, 'Corticosteroid therapy in IgA nephropathy', Journal of the American Society of Nephrology, 23, pp. 1108 - 1116, http://dx.doi.org/10.1681/ASN.2011111112

Becker GJ; Wheeler DC; De Zeeuw D; Fujita T; Furth SL; Holdaas H; Mendis S; Oparil S; Perkovic V; Saad Rodrigues CI; Sarnak MJ; Schernthaner G; Tomson CRV; Zoccali C, 2012, 'Kidney disease: Improving global outcomes (KDIGO) blood pressure work group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease', Kidney International Supplements, 2, pp. 337 - 414, http://dx.doi.org/10.1038/kisup.2012.46

Hillis GS; Hata J; Woodward M; Perkovic V; Arima H; Chow CK; Zoungas S; Patel A; Poulter NR; Mancia G; Williams B; Chalmers J, 2012, 'Resting heart rate and the risk of microvascular complications in patients with type 2 diabetes mellitus.', Journal of the American Heart Association, 1, http://dx.doi.org/10.1161/JAHA.112.002832

Jun M; Venkataraman V; Razavian M; Cooper B; Zoungas S; Ninomiya T; Webster A; Perkovic V, 2012, 'Antioxidants for chronic kidney disease', Cochrane Database of Systematic Reviews

Jun M; Badve SV; Hawley CM; Pilmore H; White S; Cass A; Perkovic V; Zoungas S, 2012, 'Glucose lowering therapies for chronic kidney disease and kidney transplantation (Protocol)', Cochrane Database of Systematic Reviews, http://dx.doi.org/10.1002/14651858.CD009966

Zhu B; Jun M; Jardine MJ; Wang YJ; Perkovic V, 2012, 'Haemodialysis duration, frequency and intensity for endstage kidney disease (Protocol)', Cochrane Database of Systematic Reviews, http://dx.doi.org/10.1002/14651858.CD010064

Toussaint ND; Pedagogos E; Tan SJ; Badve SV; Hawley CM; Perkovic V; Elder GJ, 2012, 'Phosphate in early chronic kidney disease: Associations with clinical outcomes and a target to reduce cardiovascular risk', Nephrology, 17, pp. 433 - 444, http://dx.doi.org/10.1111/j.1440-1797.2012.01618.x

Huxley RR; Barzi F; Lam TH; Czernichow S; Fang X; Welborn T; Shaw J; Ueshima H; Zimmet P; Jee SH; Patel JV; Caterson I; Perkovic V; Woodward M, 2011, 'Isolated low levels of high-density lipoprotein cholesterol are associated with an increased risk of coronary heart disease: An individual participant data meta-analysis of 23 studies in the asia-pacific region', Circulation, 124, pp. 2056 - 2064, http://dx.doi.org/10.1161/CIRCULATIONAHA.111.028373

Lambers Heerspink HJ; Perkovic V; De Zeeuw D, 2011, 'Is doubling of serum creatinine a valid clinical 'hard' endpoint in clinical nephrology trials?', Nephron - Clinical Practice, 119, http://dx.doi.org/10.1159/000327614

Badve SV; Roberts MA; Hawley CM; Cass A; Garg AX; Krum H; Tonkin A; Perkovic V, 2011, 'Effects of beta-adrenergic antagonists in patients with chronic kidney disease: A systematic review and meta-analysis', Journal of the American College of Cardiology, 58, pp. 1152 - 1161, http://dx.doi.org/10.1016/j.jacc.2011.04.041

Maione A; Navaneethan SD; Graziano G; Mitchell R; Johnson D; Mann JFE; Gao P; Craig JC; Tognoni G; Perkovic V; Nicolucci A; De Cosmo S; Sasso A; Lamacchia O; Cignarelli M; Maria Manfreda V; Gentile G; Strippoli GFM, 2011, 'Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro-and macroalbuminuria and other cardiovascular risk factors: A systematic review of randomized controlled trials', Nephrology Dialysis Transplantation, 26, pp. 2827 - 2847, http://dx.doi.org/10.1093/ndt/gfq792

Badve SV; Brown F; Hawley CM; Johnson DW; Kanellis J; Rangan GK; Perkovic V, 2011, 'Challenges of conducting a trial of uric-acid-lowering therapy in CKD', Nature Reviews Nephrology, 7, pp. 295 - 300, http://dx.doi.org/10.1038/nrneph.2010.186

Zentner D; Hunt D; Chan W; Barzi F; Grigg L; Perkovic V, 2011, 'Prospective evaluation of aortic stenosis in end-stage kidney disease: A more fulminant process?', Nephrology Dialysis Transplantation, 26, pp. 1651 - 1655, http://dx.doi.org/10.1093/ndt/gfq596

Perkovic V; Huxley R, 2011, 'Prognostic value of CRP in stable coronary artery disease unclear due to a variety of biases in existing studies, therefore no clinical practice recommendations can be made', Evidence-Based Medicine, 16, pp. 23 - 24, http://dx.doi.org/10.1136/ebm1143

Lv J; Perkovic V, 2011, 'Blood pressure management in diabetes: A path forward?', Journal of Hypertension, 29, pp. 1283 - 1284, http://dx.doi.org/10.1097/HJH.0b013e3283491537

Jun M; Jo J; Perkovic V; Jardine MJ, 2011, 'Managing cardiovascular risk in people with chronic kidney disease: A review of the evidence from randomized controlled trials', Therapeutic Advances in Chronic Disease, 2, pp. 265 - 278, http://dx.doi.org/10.1177/2040622311401775

Czernichow S; Zanchetti A; Turnbull F; Barzi F; Ninomiya T; Kengne AP; Lambers Heerspink HJ; Perkovic V; Huxley R; Arima H; Patel A; Chalmers J; Woodward M; MacMahon S; Neal B, 2011, 'The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: Meta-analysis of randomized trials', Journal of Hypertension, 29, pp. 4 - 16, http://dx.doi.org/10.1097/HJH.0b013e32834000be

Gangadharan komala M; Pianta T; Jardine MJ; Webster A; Perkovic V, 2011, 'Interventions for preventing intradialytic hypotension in haemodialysis patients (Protocol)', The Cohrane Collaboratiion, Issue 12, pp. 1 - 11

Mooney J; Ranasinghe I; Chow C; Barzi F; Zoungas S; Tan T; Perkovic V; Hillis G, 2011, 'Pre-operative Kidney Function as a Predictor of Adverse Outcomes after Surgery—A Systematic Review and Meta-analysis', Heart, Lung and Circulation, 20, pp. S212 - S212, http://dx.doi.org/10.1016/j.hlc.2011.05.521

Lambers Heerspink HJ; Ninomiya T; Perkovic V; Woodward M; Zoungas S; Cass A; Cooper M; Grobbee DE; Mancia G; Mogensen CE; Neal B; Chalmers J, 2010, 'Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease', European Heart Journal, 31, pp. 2888 - 2896, http://dx.doi.org/10.1093/eurheartj/ehq139

Baigent C; Landray M; Reith C; Dasgupta T; Emberson J; Herrington W; Lewis D; Mafham M; Collins R; Bray C; Chen Y; Baxter A; Young A; Hill M; Knott C; Cass A; Feldt-Rasmussen B; Fellström B; Grobbee R; Grönhagen-Riska C; Haas M; Holdaas H; Hooi LS; Jiang L; Kasiske B; Krairittichai U; Levin A; Massy Z; Tesar V; Walker R; Wanner C; Wheeler D; Wiȩcek A; Majoni W; Simpson D; Strony J; Musliner T; Agodoa L; Armitage J; Chen Z; Craig J; De Zeeuw D; Gaziano M; Grimm R; Krane V; Neal B; Ophascharoensuk V; Pedersen T; Sleight P; Tobert J; Tomson C; Sandercock P; Keech A; Whelton P; Yusuf S; Peto R; Parish S; Dolph L; Bahu T; Booth-Davey E; Brewster A; Yau F; Denis E; Frederick K; Haywood D; Heineman J; Howard S; Jayne K; Madgwick Z; Michell S; Murphy K; Ning L; Nolan J; Nunn M; Roberts J; Wickman M; Bowman L; Bulbulia R; Haynes R; Rahimi K; Rahman N; Ait-Sadi R; Barton I; Zhu W; Clark S; Kourellias K; Radley M; Brown K; Worthing D; Coates G; Goodenough B; Lucas N; Carreras A; Currie R; Donaldson O; Fjalling E; Gallagher M; Gibson K; Goddard J; Healy J, 2010, 'Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease', American Heart Journal, 160, pp. 785 - 794, http://dx.doi.org/10.1016/j.ahj.2010.08.012

Back to profile page